Drug Topics
APRIL 17, 2025
The subgroup analysis shows adolescents treated with the drug once daily had higher rates of clear or almost clear skin compared to patients receiving the placebo.
STAT
APRIL 17, 2025
Even before the Department of Health and Human Services announced its recent major reorganization, the media had been reporting on anticipated changes to the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. But the very last bullet on the HHS fact sheet was a complete surprise to most people: the elimination of the Administration for Community Living (ACL).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 17, 2025
LucyRx is empowering pharmacists and impacting patients health outcomes with its business model unlike other market-leading pharmacy benefit managers.
STAT
APRIL 17, 2025
For a decade and a half, Americans have been guaranteed that no matter their health insurer, certain preventive care like cancer screenings are free of charge. That’s because an Affordable Care Act provision has required insurers to fully cover services given an A or B recommendation by an expert task force. That may soon change. On Monday, the U.S.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 17, 2025
This white paper will examine some commonand costlyassumptions about vendor compliance. Well show that pharmacies must do more than meet the bare minimum to stay competitive. Well also discuss solutions that pharmacies can leverage to optimize compliance, drive savings from their primary vendor, unlock additional pharmacy savings and enhance purchasing.
STAT
APRIL 17, 2025
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday. While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
APRIL 17, 2025
A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said Thursday, results that could propel the next-generation treatment onto the market. The drug, orforglipron, produced results that were nearly comparable to the benefits of available GLP-1 drugs, which are weekly injectable treatments.
Drug Topics
APRIL 17, 2025
At AAP 2025, Greg Mitchell, owner of United Drug Superstore, discussed how retail pharmacies can leverage vaccine services to build long-term patient relationships.
STAT
APRIL 17, 2025
GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was withdrawn several years ago. The drug, which treats multiple myeloma, will be used in combination with other medicines in patients whose cancer has resurged after an earlier line of treatment, under the approval from the Medicines and Healthcare products Regulatory Agency.
European Pharmaceutical Review
APRIL 17, 2025
Over the past decade, we have witnessed the arrival of a new era in biopharmaceutical R&D. Traditional methods and processes, such as wet labs, are being augmented by a rapidly expanding digital ecosystem in pharma. Across the industry, this shift is offering extraordinary opportunities to increase the speed, accuracy, and reproducibility of research.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 17, 2025
RadNet, which runs nearly 400 radiology imaging centers in the United States, wants to put artificial intelligence into breast imaging. Over the last five years, the company has moved aggressively to expand its AI capabilities, deploying the technology for breast cancer screenings at its radiology practices. There, patients can pay $40 out-of-pocket for an algorithm to screen their mammogram, with a double-check if the AI says something different than the human radiologist reading the same
PharmaVoice
APRIL 17, 2025
The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.
Hospital Pharmacy Europe
APRIL 17, 2025
As an overall patient safety and medicines quality measure, hospital pharmacists in Belgium have mitigated critical risks in the supply chain for chimeric antigen receptor (CAR) T-cell therapies. Advanced therapy medicinal products (ATMPs), such as CAR T-cell therapies, are innovative biological drugs that demand careful management of complex supply chains.
European Pharmaceutical Review
APRIL 17, 2025
Researchers in Spain have developed a new method to deliver cell therapies to patients on extracorporeal membrane oxygenation (ECMO), a life support system for severe lung failure. The consecutive intrabronchial administration (CIBA) method enables a new route of delivery: targeted, controlled, fractionated intrabronchial delivery. The researchers referred to the novel approach as slow consecutive intrabronchial lobe-by-lobe administration.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
APRIL 17, 2025
What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.
The Checkup by Singlecare
APRIL 17, 2025
Overview: What does rapid weight gain look like? So, the numbers on the scale took a recent jump. Most people will experience some type of weight gain over their lifetimeand smaller weight fluctuations are very commonbut it can be slightly more alarming when the pounds start to add up quickly. Theres no overarching clinical definition, although a noticeable increase in body weight over a few days or weeks is typically cause for alarm and further investigation.
PharmaVoice
APRIL 17, 2025
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
The Checkup by Singlecare
APRIL 17, 2025
Saxenda ( liraglutide ) is a brand-name glucagon-like peptide-1 ( GLP-1 ) agonist made by the pharmaceutical company Novo Nordisk. It is approved by the U.S. Food and Drug Administration (FDA) for chronic weight management in adults with a starting, or baseline , body mass index ( BMI ) of 30 or more ( obesity ). It can also be used in adults with a starting BMI of 27 or more (overweight) with at least one weight-related health condition, such as high blood pressure , Type 2 diabetes , or dyslip
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
APRIL 17, 2025
Undetectable minimal residual disease rates improved with ongoing therapy.
pharmaphorum
APRIL 17, 2025
Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit
Fierce Healthcare
APRIL 17, 2025
Kennedy said the environmental toxins may be found in air, water, food or medicine. He will be launching government-funded studies to identify the toxins.
pharmaphorum
APRIL 17, 2025
A complaint against GSK alleging a major breach of the pharma industry's code of practice on prescribing information has been upheld by the PMCPA
Fierce Healthcare
APRIL 17, 2025
UnitedHealth Group cut its earnings guidance after reporting higher-than-expected care costs in its Medicare Advantage businesses, "far above" the planned 2025 increase. UnitedHealth shares fell 19% in pre-market trading Thursday.
pharmaphorum
APRIL 17, 2025
Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron
Pharmacy Times
APRIL 17, 2025
Hospital compounding is gaining renewed attention amid drug shortages, regulatory changes, and labor challenges, prompting pharmacies to leverage advanced technology for safer, more efficient, and compliant medication preparation.
pharmaphorum
APRIL 17, 2025
Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
Pharmacy Times
APRIL 17, 2025
The data showed improvements in overall response rates, progression-free survival, and duration of response.
pharmaphorum
APRIL 17, 2025
Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug
Pharmacy Times
APRIL 17, 2025
Though the rate of coronary artery lesions decreased across both cohorts of this trial of children with Kawasaki disease, there were no differences in lesion reduction between those receiving intravenous immunoglobulin (IVIG) alone and those receiving IVIG with aspirin.
Fierce Healthcare
APRIL 17, 2025
The initiative will offer peer-peer learning opportunities, tools and frameworks to implement value-based care initiatives, leveraging the operational expertise of Wilmington Health.
Pharmacy Times
APRIL 17, 2025
The implementation of hospital-based discharge pharmacy services presents a savvy strategy to improve clinical outcomes for patients while simultaneously cutting excess spending.
Pharmaceutical Commerce
APRIL 17, 2025
The interchangeability designation for Yuflyma, a biosimilar to Humira, may help to improve patient access and reduce costs.
Pharmacy Times
APRIL 17, 2025
A recent analysis from NCPA showed potential weekly cash flow shortfalls for pharmacies and annual revenue losses.
Expert insights. Personalized for you.
407 
Let's personalize your content